Therapeutic potential of nicotinamide adenine dinucleotide (NAD)

被引:13
|
作者
Arenas-Jal, Marta [1 ,2 ]
Sune-Negre, J. M. [1 ]
Garcia-Montoya, Encarna [1 ]
机构
[1] Univ Barcelona, Pharm & Pharmaceut Technol Dept, Fac Pharm & Food Sci, Barcelona, Spain
[2] Autonomous Univ Barcelona, ICN2 Catalan Inst Nanosci & Nanotechnol, Bellaterra, Barcelona, Spain
关键词
NAD; Metabolism; Therapeutic potential; Drug discovery; Supplementation; FATTY LIVER-DISEASE; NLRP3; INFLAMMASOME; CISPLATIN OTOTOXICITY; CALORIC RESTRICTION; OXIDATIVE STRESS; CELL-SURVIVAL; LIFE-SPAN; METABOLISM; SIRT1; CD38;
D O I
10.1016/j.ejphar.2020.173158
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nicotinamide adenine nucleotide (NAD) is a small ubiquitous hydrophilic cofactor that participates in several aspects of cellular metabolism. As a coenzyme it has an essential role in the regulation of energetic metabolism, but it is also a cosubstrate for enzymes that regulate fundamental biological processes such as transcriptional regulation, signaling and DNA repairing among others. The fluctuation and oxidative state of NAD levels regulate the activity of these enzymes, which is translated into marked effects on cellular function. While alterations in NAD homeostasis are a common feature of different conditions and age-associated diseases, in general, increased NAD levels have been associated with beneficial health effects. Due to its therapeutic potential, the interest in this molecule has been renewed, and the regulation of NAD metabolism has become an attractive target for drug discovery. In fact, different approaches to replenish or increase NAD levels have been tested, including enhancement of biosynthesis and inhibition of NAD breakdown. Despite further research is needed, this review provides an overview and update on NAD metabolism, including the therapeutic potential of its regulation, as well as pharmacokinetics, safety, precautions and formulation challenges of NAD supplementation.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Nicotinamide adenine dinucleotide emerges as a therapeutic target in aging and ischemic conditions
    Hosseini, Leila
    Vafaee, Manouchehr S.
    Mahmoudi, Javad
    Badalzadeh, Reza
    BIOGERONTOLOGY, 2019, 20 (04) : 381 - 395
  • [22] Nicotinamide Adenine Dinucleotide (NAD+) Repletion Attenuates Bupivacaine-Induced Neurotoxicity
    Ting Zheng
    Shi Yuan Xu
    Shu Qin Zhou
    Lu Ying Lai
    Le Li
    Neurochemical Research, 2013, 38 : 1880 - 1894
  • [23] The role of diadenosine pentaphosphate and nicotinamide adenine dinucleotide (NAD+) as potential nucleotide comediators in the adrenergic regulation of cardiac function
    N. V. Pakhomov
    K. B. Pustovit
    D. V. Abramochkin
    V. S. Kuz’min
    Neurochemical Journal, 2017, 11 : 63 - 71
  • [24] Nicotinamide adenine dinucleotide: Biosynthesis, consumption and therapeutic role in cardiac diseases
    Tannous, Cynthia
    Booz, George W.
    Altara, Raffaele
    Muhieddine, Dina H.
    Mericskay, Mathias
    Refaat, Marwan M.
    Zouein, Fouad A.
    ACTA PHYSIOLOGICA, 2021, 231 (03)
  • [25] A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD) plus Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction
    Kahn, Benjamin
    Borrelli, Mimi
    Libby, Tiffany
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (10) : 1129 - 1132
  • [26] The Role of Diadenosine Pentaphosphate and Nicotinamide Adenine Dinucleotide (NAD plus ) as Potential Nucleotide Comediators in the Adrenergic Regulation of Cardiac Function
    Pakhomov, N. V.
    Pustovit, K. B.
    Abramochkin, D. V.
    Kuz'min, V. S.
    NEUROCHEMICAL JOURNAL, 2017, 11 (01) : 63 - 71
  • [27] Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues
    Petrelli, Riccardo
    Sham, Yuk Yin
    Chen, Liqiang
    Felczak, Krzysztof
    Bennett, Eric
    Wilson, Daniel
    Aldrich, Courtney
    Yu, Jose S.
    Cappellacci, Loredana
    Franchetti, Palmarisa
    Grifantini, Mario
    Mazzola, Francesca
    Di Stefano, Michele
    Magni, Giulio
    Pankiewicz, Krzysztof W.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (15) : 5656 - 5664
  • [28] Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress
    Sharma, Pratibha
    Xu, Jihong
    Williams, Katie
    Easley, Michelle
    Elder, J. Brad
    Lonser, Russell
    Lang, Frederick F.
    Lapalombella, Rosa
    Sampath, Deepa
    Puduvalli, Vinay K.
    NEURO-ONCOLOGY, 2022, 24 (02) : 229 - 244
  • [29] Rationale for Nicotinamide Adenine Dinucleotide (NAD+) Metabolome Disruption as a Pathogenic Mechanism of Post-Acute COVID-19 Syndrome
    Block, Tabitha
    Kuo, Jonathann
    CLINICAL PATHOLOGY, 2022, 15
  • [30] Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
    Bhasin, Shalender
    Seals, Douglas
    Migaud, Marie
    Musi, Nicolas
    Baur, Joseph A.
    ENDOCRINE REVIEWS, 2023, 44 (06) : 1047 - 1073